Factor XI inhibitors in early clinical trials: a meta-analysis
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI inhibitors in early clinical trials: a meta-analysis.
M Galli, R Laborante, L Ortega-Paz… - Thrombosis and …, 2023 - europepmc.org
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI inhibitors in early clinical trials: a meta-analysis
M Galli, R Laborante, L Ortega-Paz… - European Heart …, 2023 - academic.oup.com
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
M Galli, R Laborante, L Ortega-Paz, F Franchi… - THROMBOSIS AND …, 2023 - iris.uniupo.it
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
M Galli, R Laborante, L Ortega-Paz… - Thrombosis and …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
M Galli, R Laborante, L Ortega-Paz… - Thrombosis and …, 2023 - thieme-connect.com
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
M Galli, R Laborante, L Ortega-Paz… - Thrombosis and …, 2023 - research.uniupo.it
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
M Galli, R Laborante, L Ortega-Paz… - Thrombosis and …, 2023 - research.uniupo.it
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …
Factor XI inhibitors in early clinical trials: a meta-analysis
M Galli, R Laborante, L Ortega-Paz… - European Heart …, 2023 - academic.oup.com
Background Phase II randomized controlled trials (RCTs) on factor (F) XI inhibitors have
shown promising results but they were burdened by low statistical power for clinical …
shown promising results but they were burdened by low statistical power for clinical …